<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medecol</journal-id><journal-title-group><journal-title xml:lang="ru">Медицина и экология</journal-title><trans-title-group xml:lang="en"><trans-title>Medicine and ecology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-6045</issn><issn pub-type="epub">2305-6053</issn><publisher><publisher-name>Карагандинский медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.59598/ME-2305-6045-2023-107-2-14-18</article-id><article-id custom-type="elpub" pub-id-type="custom">medecol-412</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТЕОРЕТИЧЕСКАЯ И ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>THEORETICAL AND EXPERIMENTAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Кратко о стволовых клетках и регенеративной медицине для практики</article-title><trans-title-group xml:lang="en"><trans-title>Briefly on stem cells and regenerative medicine for practice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ческа</surname><given-names>А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chesca</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Факультет медицины</p><p>г. Брашов</p></bio><bio xml:lang="en"><p>Antonella Chesca – MD, PhD Head of Imagistic Department. at Clinic Lung Physiology Hospital, Brasov; Head of Cell and Molecular Biology and Histology at, Faculty of Medicine</p><p>Brasov</p></bio><email xlink:type="simple">anto.chesca@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдулина</surname><given-names>Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdulina</surname><given-names>G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Караганда</p></bio><bio xml:lang="en"><p>Karaganda</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Университет Трансильвании г. Брашов<country>Румыния</country></aff><aff xml:lang="en">Transilvania University of Brasov<country>Romania</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Карагандинский медицинский университет<country>Казахстан</country></aff><aff xml:lang="en">Karaganda Medical University<country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>30</day><month>08</month><year>2023</year></pub-date><volume>0</volume><issue>2</issue><fpage>14</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ческа А., Абдулина Г., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Ческа А., Абдулина Г.</copyright-holder><copyright-holder xml:lang="en">Chesca A., Abdulina G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medecol.qmu.kz/jour/article/view/412">https://medecol.qmu.kz/jour/article/view/412</self-uri><abstract><p>Стволовые клетки можно использовать в клеточной терапии. Это необходимо для замены поврежденных клеток или с целью регенерации органов. Определение стволовых клеток можно расширить. С этой точки зрения мы можем упомянуть принятие во внимание идеи, согласно которой известно, что эти клетки образуют основу строительного материала. Более того, мы можем упомянуть, что стволовые клетки характеризуются двумя известными свойствами, а именно дифференцировкой и самообновлением. Основываясь на наблюдении, что дифференцировку взрослых стволовых клеток в специфические производные можно контролировать с помощью лабораторных методов, ожидается, что взрослые стволовые клетки могут стать основой для лечения многих и различных типов заболеваний. Регенеративная медицина базируется на использование стволовых, в настоящее время широко известна как одна из самых обсуждаемых тем в биотехнологии. В то же время ученые обращают внимание на влияние регенеративной медицины с использованием стволовых клеток в рутинной медицинской практике для лечения. С этой целью стволовые клетки можно использовать в регенеративной медицине. Принципы регенерации разных типов культур известны с давних времен. В конце 20 века возникла необходимость в высокоэффективных клеточных технологиях, что привело к созданию тканевой инженерии.</p></abstract><trans-abstract xml:lang="en"><p>Stem cells can be used in cellular therapy. This happened in order to replace damaged cells or having aim to regenerate organs. The definition of stem cells can be extended. From this point of view, we can mention taking in consideration the idea in which it is known that these cells form the base of the building body. More than, we can mention, that stem cells are characterized by two knowing properties – namely differentiation and self-renewal. Based on the observation that differentiation of adult stem cells into specific derivatives can be controlled by laboratory techniques, it is anticipated that adult stem cells may become the basis of therapies for many, and various types of medical conditions. Taking on stem cells, regenerative medicine (RM) it is known as being one of the hottest topics in biotechnology nowadays.</p><p>From this purpose, stem cells can be used in regenerative medicine (RM). The principles of regeneration are found in different types of cultures, from long time ago, centuries etc.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>диагностика</kwd><kwd>стволовые клетки</kwd><kwd>организм человека</kwd><kwd>трансплантация</kwd><kwd>регенеративная медицина</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diagnostic</kwd><kwd>stem cells</kwd><kwd>human body</kwd><kwd>transplantations</kwd><kwd>regenerative medicine</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Li M., Ma J., Gao Y., Yang L. Cell sheet technology: a promising strategy in regenerative medicine. Cytotherapy. 2019; 21(1): 3-16.</mixed-citation><mixed-citation xml:lang="en">Li M., Ma J., Gao Y., Yang L. Cell sheet technology: a promising strategy in regenerative medicine. Cytotherapy. 2019; 21(1): 3-16.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberg R. S. Transfusion medicine and hemostasis. Elsevier; 2019. Overview of cellular therapy; pp. 505-512.</mixed-citation><mixed-citation xml:lang="en">Weinberg R. S. Transfusion medicine and hemostasis. Elsevier; 2019. Overview of cellular therapy; pp. 505-512.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Mahla R. S. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016; 2016: 6940283.</mixed-citation><mixed-citation xml:lang="en">Mahla R. S. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016; 2016: 6940283.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Barker C. F. &amp; Markmann, J.F. Historical overview of transplantation. Cold Spring Harb. Perspect. Med. 3, 1-18 (2013).</mixed-citation><mixed-citation xml:lang="en">Barker C. F. &amp; Markmann, J.F. Historical overview of transplantation. Cold Spring Harb. Perspect. Med. 3, 1-18 (2013).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sampogna G., Guraya S.Y. &amp; Forgione, A. Regenerative medicine: historical roots and potential strategies in modern medicine. J. Microsc. Ultrastruct. 3, 101-107 (2015).</mixed-citation><mixed-citation xml:lang="en">Sampogna G., Guraya S.Y. &amp; Forgione, A. Regenerative medicine: historical roots and potential strategies in modern medicine. J. Microsc. Ultrastruct. 3, 101-107 (2015).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Slingerland A.S., Smits, A.I.P.M. &amp; Bouten, C.V.C. Then and now: hypes and hopes of regenerative medicine. Trends Biotechnol. 31, 121–123 (2013).</mixed-citation><mixed-citation xml:lang="en">Slingerland A.S., Smits, A.I.P.M. &amp; Bouten, C.V.C. Then and now: hypes and hopes of regenerative medicine. Trends Biotechnol. 31, 121–123 (2013).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451(7175):141–6.</mixed-citation><mixed-citation xml:lang="en">Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451(7175):141–6.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Terzic A., Pfenning, M.A., Gores, G.J. &amp; Harper, C.M. Jr. Regenerative medicine build-out. Stem Cells Transl. Med. 4, 1373–1379 (2015).</mixed-citation><mixed-citation xml:lang="en">Terzic A., Pfenning, M.A., Gores, G.J. &amp; Harper, C.M. Jr. Regenerative medicine build-out. Stem Cells Transl. Med. 4, 1373–1379 (2015).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kaul, H. &amp; Ventikos, Y. On the genealogy of tissue engineering and regenerative medicine. Tissue Eng. Part B Rev. 21, 203–217 (2015).</mixed-citation><mixed-citation xml:lang="en">Kaul, H. &amp; Ventikos, Y. On the genealogy of tissue engineering and regenerative medicine. Tissue Eng. Part B Rev. 21, 203–217 (2015).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Broughton K.M. &amp; Sussman M.A. Enhancement strategies for cardiac regenerative cell therapy. Circ. Res. 123, 177–187 (2018).</mixed-citation><mixed-citation xml:lang="en">Broughton K.M. &amp; Sussman M.A. Enhancement strategies for cardiac regenerative cell therapy. Circ. Res. 123, 177–187 (2018).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Allickson J. G. Emerging translation of regenerative therapies. Clin. Pharmacol. Ther. 101, 28–30 (2017).</mixed-citation><mixed-citation xml:lang="en">Allickson J. G. Emerging translation of regenerative therapies. Clin. Pharmacol. Ther. 101, 28–30 (2017).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Heathman T. R., Nienow, A.W., McCall M.J., Coopman K., Kara, B. &amp; Hewitt, C. J. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen. Med. 10, 49–64 (2015).</mixed-citation><mixed-citation xml:lang="en">Heathman T. R., Nienow, A.W., McCall M.J., Coopman K., Kara, B. &amp; Hewitt, C. J. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen. Med. 10, 49–64 (2015).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 2008 Epub ahead of print.</mixed-citation><mixed-citation xml:lang="en">Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 2008 Epub ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mount N. M., Ward, S.J., Kefalas, P. &amp; Hyllner, J. Cell-based therapy technology classifications and translational challenges. Philos. Trans. R. Soc. B Biol. Sci. 370, 20150017 (2015).</mixed-citation><mixed-citation xml:lang="en">Mount N. M., Ward, S.J., Kefalas, P. &amp; Hyllner, J. Cell-based therapy technology classifications and translational challenges. Philos. Trans. R. Soc. B Biol. Sci. 370, 20150017 (2015).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453(7194): 524</mixed-citation><mixed-citation xml:lang="en">Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453(7194): 524</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotech. 2008; 26(1):101–106.</mixed-citation><mixed-citation xml:lang="en">Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotech. 2008; 26(1):101–106.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Smit F. E. &amp; Dohmen, P. M. Cardiovascular tissue engineering: where we come from and where are we now? Med. Sci. Monit. Basic Res. 20, 1–3 (2014)/</mixed-citation><mixed-citation xml:lang="en">Smit F. E. &amp; Dohmen, P. M. Cardiovascular tissue engineering: where we come from and where are we now? Med. Sci. Monit. Basic Res. 20, 1–3 (2014)/</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with parkinson’s disease. Proc Natl Acad Sci USA. 2008; 105(15):5856 – 61.</mixed-citation><mixed-citation xml:lang="en">Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with parkinson’s disease. Proc Natl Acad Sci USA. 2008; 105(15):5856 – 61.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Greenfield JP, Ayuso-Sacido A, Schwartz TH, et al. Use of human neural tissue for the generation of progenitors. Neurosurgery. 2008; 62(1): 21–37.</mixed-citation><mixed-citation xml:lang="en">Greenfield JP, Ayuso-Sacido A, Schwartz TH, et al. Use of human neural tissue for the generation of progenitors. Neurosurgery. 2008; 62(1): 21–37.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yamanaka S, Jinliang Li, Kania G, et al. Pluripotency of embryonic stem cells. Cell Tissue Res. 2008; 331: 5–22.</mixed-citation><mixed-citation xml:lang="en">Yamanaka S, Jinliang Li, Kania G, et al. Pluripotency of embryonic stem cells. Cell Tissue Res. 2008; 331: 5–22.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ptaszek L.M., Mansour M., Ruskin J.N., Chien K.R. Towards regenerative therapy for cardiac disease. Lancet. 2012; 379 (9819): 933–942.</mixed-citation><mixed-citation xml:lang="en">Ptaszek L.M., Mansour M., Ruskin J.N., Chien K.R. Towards regenerative therapy for cardiac disease. Lancet. 2012; 379 (9819): 933–942.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Li M., Ma J., Gao Y., Yang L. Cell sheet technology: a promising strategy in regenerative medicine. Cytotherapy. 2019; 21(1):3–16.</mixed-citation><mixed-citation xml:lang="en">Li M., Ma J., Gao Y., Yang L. Cell sheet technology: a promising strategy in regenerative medicine. Cytotherapy. 2019; 21(1):3–16.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberg R. S. Transfusion medicine and hemostasis. Elsevier; 2019. Overview of cellular therapy; pp. 505–512.</mixed-citation><mixed-citation xml:lang="en">Weinberg R. S. Transfusion medicine and hemostasis. Elsevier; 2019. Overview of cellular therapy; pp. 505–512.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mahla R.S. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016; 2016: 6940283.</mixed-citation><mixed-citation xml:lang="en">Mahla R.S. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016; 2016: 6940283.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kolios G., Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013; 85(1):3–10.</mixed-citation><mixed-citation xml:lang="en">Kolios G., Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013; 85(1):3–10.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
